RESIST-TB Webinar on Quabodepistat Phase 2bc Study

6 September 2024

RESIST-TB will host a webinar on 12 September 2024 to present the results of the interim analysis of the quabodepistat Phase 2bc study for pulmonary TB – a 4-month regimen of quabodepistat, delamanid, and bedaquiline.

Register for the webinar here.

Source: RESIST-TB